Gastrointestinal therapeutics Market Research Reports

"...... porate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Inflammatory Bowel Disease Drugs industry, providing statistical information about market dynamics, growth factors, major......"

"...... te Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries covers and analyzes the potential of the global Irritable Bowel Syndrome (IBS) industry, providing statistical information about market dynamics, growth factors, major chall......"

"...... nant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%. North America is the la......"

"...... tion, and Leading 20 Countries covers and analyzes the potential of the global Pentasa industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opportunitie......"

"...... H2 Antagonists - Ulcer Protective Drugs United States Anti-Peptic Ulcer Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Anti-Peptic Ulcer Drugs Market Segment Percentages, By Application, 202......"

"...... . Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers. Market Analysis and Insights: G......"

"...... table Bowel Syndrome (IBS) market was valued at 4250.5 million in 2020 and is projected to reach US$ 7268.7 million by 2027, at a CAGR of 14.4% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Irritable Bowel......"

"...... tions, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research, the global Anti-Peptic Ulcer Drugs siz......"

"...... apeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage Erosive esophagitis Under......"

"...... br /> Global top five Anti-Peptic Ulcer Drugs companies in 2020 (%) The global Anti-Peptic Ulcer Drugs market was valued at 7914.3 million in 2020 and is projected to reach US$ 12820 million by 2027, at a CAGR of 12.8% during the foreca......"